Bozena Jazwiec - Publications

Prognostic Impact of Copy Number Alterations' Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy.

Journal: Cancers

Published: October 09, 2023

Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia.

Journal: International journal of molecular sciences

Published: July 14, 2022

Infection and expression of Toll-like receptors in lymphoid malignancy patients after autologous stem cell transplantation.

Journal: Central-European journal of immunology

Published: August 12, 2021

A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.

Journal: BMC medical genomics

Published: July 01, 2021

What factors determine the pregnancy outcome in patients with essential thrombocythemia?

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: April 01, 2021

Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function.

Journal: Pharmacology

Published: June 03, 2020

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.

Journal: Scientific reports

Published: March 02, 2020

Influence of temperature rise by 2.5°C on the increase of apoptosis of HL-60 cells treated with busulfan.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: January 27, 2019

Expression of the PIM2 gene is associated with more aggressive clinical course in patients with chronic lymphocytic leukemia.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: December 08, 2018

Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.

Journal: Leukemia research

Published: November 16, 2017

The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.

Journal: Archivum immunologiae et therapiae experimentalis

Published: June 28, 2016

The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience.

Journal: Disease markers

Published: March 17, 2016